Johnson & Johnson News and Healthcare Innovation
266.17
4.3900
1.62 %
At close
11/03
USD
Daily range
265.28
271.07
271.07
Weekly range
265.28
277.73
277.73
Smith+Nephew cuts outlook after ending J&J orthopaedics merger talks
Smith+Nephew is lowering its full-year revenue and profit expectations as weak growth in its Orthopaedics unit continues into the final quarter. The UK medical technology company also confirms ...
Johnson & Johnson shares weekly forecast: Consolidation expected as price volatility and resistance limit upside
Shares of Johnson & Johnson (JNJ) are trading near $275 after rising more than 4% this week as recovery momentum persists. Strong corporate fundamentals continue to ...
Johnson & Johnson announces quarterly dividend and earnings guidance: Can JNJ continue gains?
Johnson & Johnson (JNJ) stock is trading at $272.05 after a 3.1% gain on the day. The price sits above its key moving averages, reflecting a firm position in both short- ...
Johnson & Johnson reports early-stage prostate cancer drug trial response
Johnson & Johnson says its experimental once-daily oral prostate cancer treatment shows tumor shrinkage or disappearance in an early-stage study of patients with advanced disease. The candidate, ...
Johnson & Johnson launches TECNIS PureSee lens: Can it spark further gains for JNJ stock?
Johnson & Johnson (JNJ) stock is trading at $267.22, up 3.7% on the day. The price currently sits above its key moving averages, showing positive momentum relative to ...
Johnson & Johnson shares contained by resistance at $265.07 as oscillators flash mixed signals: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $263 after gaining around 3% over the past week. The chart shows recovery could continue, but conflicting technical ...
Johnson & Johnson stock faces resistance at $259.89 during consolidation: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $259 as a recent pullback leaves the stock in oversold territory. Technical momentum has lost steam, with mixed ...
Cramer highlights Goldman, Wells Fargo and Johnson & Johnson as buys amid market weakness
Investor sentiment remains fragile as bank earnings and pressure on memory stocks weigh on Tuesday trading. Against that backdrop, Jim Cramer argues that selected shares still offer buying ...
Johnson & Johnson stock falls as weak momentum dominates short-term trading
Johnson & Johnson (JNJ) stock is trading at $251.79, down 4.64% for the day. The price currently sits below its key short- and medium-term moving averages while ...
Johnson & Johnson raises full-year outlook as drug sales offset medical device pressure
Johnson & Johnson posts third-quarter revenue and profit above Wall Street estimates as strong demand for autoimmune treatment Tremfya supports its pharmaceutical business. The results also show ...
Wall Street outlook focuses on bank earnings, Dell appearance and industrial updates
U.S. stocks head into Tuesday with investors watching corporate catalysts after the S&P 500 finished nearly flat Monday amid higher oil prices and weakness in memory chip shares. The next session ...
Johnson & Johnson stock remains below resistance with MACD signaling a sell: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $253, extending their decline this week as the chart now signals oversold conditions and mounting short-term pressure. ...
Johnson & Johnson shares trade within narrow range as market awaits earnings catalyst: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $263 after a decline of just over 3% last week, landing the stock in oversold territory on several momentum signals. ...
Johnson & Johnson stock weekly forecast: Holds top of recent range with potential pause near current levels
Shares of Johnson & Johnson (JNJ) are trading near $274, extending their recovery with an advance of around 1.6% over the past week as upbeat corporate news fueled ...
Johnson & Johnson shares test modest upside with bullish MACD flashing 'Strong Buy': weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $268 after a move of just over 1% higher last week, as competing technical signals keep the bias contained. While ...
AI stocks face pressure as Wall Street tracks safety push, deal talks and analyst calls
Wall Street is heading into Monday's session with sharp pressure on AI semiconductor and infrastructure shares as investors reassess the pace of artificial intelligence development. The market ...
Johnson & Johnson stock trades below 20-day average as technical signals clash: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $267 after falling nearly 3% this week as the decline stretches into oversold territory. The daily chart highlights ...
Johnson & Johnson shares weekly forecast: Upward momentum persists with strong MACD signals
Shares of Johnson & Johnson (JNJ) are trading near $276, extending their recovery with a gain of almost 3% over the past week as investors remain attracted by the ...
Johnson & Johnson shares weekly forecast: Buyers remain in control as resistance at $273.98 approaches
Shares of Johnson & Johnson (JNJ) are trading near $272 as recovery momentum continues into a new week. The advance has been relatively modest, but buyers retain control ...
Shield Therapeutics lifts H1 revenue 42% as it stays on track for 2026 profitability
Shield Therapeutics reports stronger first-half sales and a sharply narrower loss for the six months ended June 30, 2026, as demand for its iron deficiency treatment ACCRUFeR continues to grow in ...
Johnson & Johnson shares weekly forecast: Strong earnings help sustain upside as momentum persists
Shares of Johnson & Johnson (JNJ) are trading near $275, climbing nearly 6% over the past week as a recovery setup holds firm. Strong earnings and upbeat corporate ...
